Preventing exposure keratopathy in the critically ill: a prospective study comparing eye care regimes.
Ezra
D G
DG
Lewis
G
G
Healy
M
M
Coombes
A
A
D000178:Acrylamides / Q000627:therapeutic use; D000362:Agar / Q000627:therapeutic use; D002724:Chlorobutanol / Q000627:therapeutic use; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness / Q000628:therapy*; D004338:Drug Combinations; D006801:Humans; D007634:Keratitis / Q000517:prevention & control*; D007809:Lanolin / Q000627:therapeutic use; D008899:Mineral Oil / Q000627:therapeutic use; D010577:Petrolatum / Q000627:therapeutic use; D011446:Prospective Studies; D012720:Severity of Illness Index
D000178:Acrylamides; D004338:Drug Combinations; C044284:Geliperm; C014633:lacri-lube; D007809:Lanolin; D010577:Petrolatum; D008899:Mineral Oil; D000362:Agar; D002724:Chlorobutanol